Value of adjuvant chemotherapy for patients with pT2N0M0 non‐small cell lung cancer receiving radical resection

Value of adjuvant chemotherapy for patients with pT2N0M0 non‐small cell lung cancer receiving radical resection

Abstract Background Associations between adjuvant chemotherapy (ACT) and the improvement in survival for patients with pT2N0M0 non‐small cell lung cancer (NSCLC) who received R0 resection remain controversial. This study aimed to evaluate the value of ACT for patients with pT2N0M0 NSCLCs, and to ide...

Full description

Bibliographic Details
Main Authors: Shiqi Chen, Siqian Yang, Yue Zhao, Yang Zhang, Qingyuan Huang, Haoxuan Wu, Hong Hu, Yihua Sun, Yawei Zhang, Jiaqing Xiang, Ting Ye, Haiquan Chen
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Thoracic Cancer
Subjects:
adjuvant chemotherapy
non‐small cell lung cancer
pT2N0M0
radical resection
Online Access:https://doi.org/10.1111/1759-7714.15192

Internet

https://doi.org/10.1111/1759-7714.15192

Similar Items